| Name | Title | Contact Details |
|---|---|---|
Cheryl Johnson |
Chief Financial Officer, Garden Park Medical Center | Profile |
At PharmScript, we are healthcare professionals first. Together, we believe in the power of helping our clients deliver true patient-centered care.
Inogent is a Bethesda, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Odan Laboratories is a Pointe-Claire, QC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
ProNAi Therapeutics is a clinical-stage oncology company pioneering a novel class of therapeutics based on its proprietary DNAi technology platform for patients with cancer and hematological diseases. ProNAi`s lead DNAi product candidate, PNT2258, is designed to treat cancers that overexpress BCL2, an important and validated oncogene known to be dysregulated in many types of cancer. ProNAi is pursuing a multi-faceted clinical development strategy designed to efficiently achieve regulatory approval and maximize the commercial opportunity of PNT2258. ProNAi recently initiated "Wolverine", a Phase 2 trial evaluating PNT2258 for the treatment of relapsed or refractory diffuse large B-cell lymphoma.
Travanti Pharma is a Saint Paul, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.